| CRISPR Therapeutics AG. (10/10/18). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease". Zug, Boston, MA & Cambridge, MA |
2018-10-10 |
| SphingoTec GmbH. (10/8/18). "Press Release: SphingoTec Raises €20 Million from HBM and Wellington Partners". Hennigsdorf. |
2018-10-08 |
| Genedata AG. (10/2/18). "Press Release: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors". Basel. |
2018-10-02 |
| Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. |
2018-09-28 |
| Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel. |
2018-09-27 |
| SGS S.A.. (9/26/18). "Press Release: SGS Issues CHF 225 Million and CHF 175 Million Bonds [NOT FOR DISTRIBUTION IN THE UNITED STATES et al.]". |
2018-09-26 |
| Aktiia S.A.. (9/25/18). "Press Release: Aktiia Closes 4M Seed Round to Reinvent Blood Pressure Monitoring". Neuchâtel. |
2018-09-25 |
| MaxiVax S.A.. (9/25/18). "Press Release: MaxiVax Starts Phase 2 Study in Switzerland of Innovative Cancer Vaccine in Patients with Head & Neck Cancer". Geneva. |
2018-09-25 |
| Tolremo Therapeutics AG. (9/24/18). "Press Release: Tolremo Raises CHF 9 Million Series A Financing Round and Strengthens Board of Directors with Industry Experts". Zurich. |
2018-09-24 |
| Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G |
2018-09-20 |
| Lonza Group Ltd.. (9/20/18). "Press Release: Lonza Expands Ibex Solutions to Offer Complete Product Lifecycle Management in One Location". Basel. |
2018-09-20 |
| CRISPR Therapeutics AG. (9/19/18). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. |
2018-09-19 |
| Neurimmune AG. (9/18/18). "Press Release: Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical". Schlieren. |
2018-09-18 |
| GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. |
2018-09-18 |
| Roche. (9/18/18). "Press Release: Roche’s NAVIFY Decision Support Portfolio Unlocks Relevant Content from Clinical Trial and Medical Publication Databases". Basel. |
2018-09-18 |
| CRISPR Therapeutics AG. (9/17/18). "Press Release: CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes". Zug, Cambridge, MA & San Diego, CA. |
2018-09-17 |
| Luciole Medical AG. (9/17/18). "Press Release: Luciole Medical Raises CHF 5.3 Million in Series A Financing for Novel Brain Monitoring Platform". Zürich. |
2018-09-17 |
| Neurimmune AG. (9/12/18). "Press Release: Neurimmune Appoints Christoph Hock as Chief Medical Officer to Lead Clinical Development". Schlieren. |
2018-09-12 |
| Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. |
2018-09-11 |
| Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. |
2018-09-09 |
| Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. |
2018-09-06 |
| Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. |
2018-09-06 |
| Twentyeight-Seven. (9/6/18). "Press Release: Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding". Cambridge, MA. |
2018-09-06 |
| Creoptix AG. (9/5/18). "Press Release: Creoptix Attracts Waters as Corporate Investor". Wädenswil (Zurich). |
2018-09-05 |
| Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. |
2018-09-04 |
| Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. |
2018-09-03 |
| Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. |
2018-08-30 |
| Novartis AG. (8/29/18). "Press Release: Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma". Basel. |
2018-08-29 |
| Novartis AG. (8/29/18). "Press Release: European Commission Approves Novartis Combination Therapy Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600 Mutation-positive Melanoma". Basel. |
2018-08-29 |
| Roivant Sciences GmbH. (8/28/18). "Press Release: Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder". Basel & Irvine, CA. |
2018-08-28 |
| Novartis AG. (8/27/18). "Press Release: Novartis Receives European Commission Approval of Its CAR-T Cell Therapy, Kymriah (tisagenlecleucel)". Basel. |
2018-08-27 |
| Proteomedix AG. (8/27/18). "Press Release: Proteomedix Raises CHF 5.2 Million in Financing Round". |
2018-08-27 |
| Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel. |
2018-08-23 |
| Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug. |
2018-08-22 |
| Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel. |
2018-08-20 |
| Genedata AG. (8/20/18). "Press Release: Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D". San Francisco, CA. |
2018-08-20 |
| Tecan Group Ltd.. (8/16/18). "Press Release: Tecan Accelerates Broad Genomics Strategy with the Acquisition of NuGen Technologies". Männedorf. |
2018-08-16 |
| Tecan Group Ltd.. (8/16/18). "Press Release: H1 2018 – Tecan Posts Strong Increase in Sales, Driven by Growth in the Partnering Business". Männedorf. |
2018-08-16 |
| CRISPR Therapeutics AG. (8/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results". Zug & Cambridge, MA. |
2018-08-07 |
| Akouos. (8/7/18). "Press Release: Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing". Boston, MA. |
2018-08-07 |
| Roche. (8/3/18). "Press Release: PRIME Designation Granted by European Medicines Agency for RG6042 for Treatment of Huntington’s Disease". Basel. |
2018-08-03 |
| Roche. (7/31/18). "Press Release: Roche Purchases Shares in Tender Offer for FMI". Basel. |
2018-07-31 |
| Novartis AG. (7/30/18). "Press Release: Novartis Marks a New Era for Migraine Patients with the EU Approval of Aimovig, a First-of-its-Kind Treatment Specifically Designed for Migraine Prevention". Basel. |
2018-07-30 |
| Metrohm. (7/27/18). "Press Release: Metrohm Acquires B&W Tek". |
2018-07-27 |
| Roche. (7/26/18). "Press Release: Roche Reports Very Strong Performance in the First Half of 2018". Basel. |
2018-07-26 |
| Sanofi S.A.. (7/26/18). "Press Release: Sanofi Head of Human Resources Roberto Pucci to Retire, Company Names Caroline Luscombe to Take over October 1st". Paris. |
2018-07-26 |
| Roche. (7/23/18). "Press Release: Roche Receives CE Mark for Its Accu-Chek Solo Micropump System". Basel. |
2018-07-23 |
| MorphoSys AG. (7/19/18). "Press Release: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Pharma Partner". Planegg & Mechelen. |
2018-07-19 |
| Roche. (7/18/18). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Tecentriq in Combination with Avastin as First-line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)". Basel. |
2018-07-18 |
| Polares Medical S.A.. (7/17/18). "Press Release: Polares Medical Closes a $25m Financing to Enter Clinical Validation". Lausanne & Palo Alto, CA. |
2018-07-17 |
| Roche. (7/17/18). "Press Release: Phase III CAPSTONE-2 Study Showed that Baloxavir Marboxil Reduced Symptoms in People at High Risk of Complications from the Flu". Basel. |
2018-07-17 |
| Polyphor Ltd.. (7/17/18). "Press Release: Polyphor Announces Listing of New Shares Related to the Convertible Loan Facility Agreement with the Wellcome Trust (Ad-hoc Announcement)". |
2018-07-17 |
| Consilium Strategic Communications Ltd.. (7/17/18). "Press Release: Consilium Strategic Communications Advises Polyphor on its Successful CHF 155 Million (c. €130 Million) Fundraise and IPO on the SIX Swiss Exchange". London. |
2018-07-17 |
| Mosa Meat B.V.. (7/17/18). "Press Release: Mosa Meat Raises €7.5m to Commercialise Cultured Meat". Maastricht. |
2018-07-17 |
| Evolva Holding S.A.. (7/10/18). "Press Release: Evolva Announces Oliver Walker to Succeed Simon Waddington as CEO". |
2018-07-10 |
| Dynacure SAS. (7/10/18). "Press Release: Dynacure Names Chris Freitag (MD) Chief Medical Officer". Strasbourg. |
2018-07-10 |
| Genedata AG. (7/10/18). "Press Release: MyBio Adopts Genedata for Improving Antibiotic Production Processes". Munich. |
2018-07-10 |
| Codexis, Inc.. (7/9/18). "Press Release: Codexis Doses First Subjects in Phase 1a Trial of CDX-6114. Triggers $4 Million Milestone Payment under Strategic Collaboration with Nestlé Health Science". Redwood City, CA. |
2018-07-09 |
| Coulter Partners. (7/4/18). "Press Release: Coulter Partners Secures Chief Technology Officer for Basilea Pharmaceutica International Ltd.". |
2018-07-04 |
| Cytosurge AG. (6/29/18). "Press Release: Partnership between Bruker and Cytosurge – Enabling FluidFM Single Cell Experiments on the BioScope Resolve BioAFM". Zurich / Glattbrugg. |
2018-06-29 |
| Kymab Ltd.. (6/28/18). "Press Release: Kymab and Roche Clinical Trial Agreement for KY1044". Cambridge. |
2018-06-28 |
| NBE Therapeutics AG. (6/28/18). "Press Release: NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S". Basel. |
2018-06-28 |
| Bruker Corporation. (6/27/18). "Press Release: Bruker Introduces FluidFM on the BioScope Resolve BioAFM". Santa Barbara, CA. |
2018-06-27 |
| ProBioGen AG. (6/26/18). "Press Release: ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Basel. |
2018-06-26 |
| Roche. (6/22/18). "Press Release: Changes to the Roche Enlarged Corporate Executive Committee". Basel. |
2018-06-22 |
| Novimmune S.A.. (6/20/18). "Press Release: TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody". New York, NY & Geneva. |
2018-06-20 |
| Idorsia Ltd.. (6/20/18). "Press Release: Idorsia Initiates PRECISION Phase 3 Study with Aprocitentan for Resistant Hypertension Management". Allschwil. |
2018-06-20 |
| Roche. (6/19/18). "Press Release: Roche and Foundation Medicine Reach Definitive Merger Agreement to Accelerate Broad Availability of Comprehensive Genomic Profiling in Oncology". Basel. |
2018-06-19 |
| Idorsia Ltd.. (6/18/18). "Press Release: Idorsia Is Initiating REACT - Phase 3 Registration Study with Clazosentan". Allschwil. |
2018-06-18 |
| Sophia Genetics S.A.. (6/16/18). "Press Release: Sophia Genetics Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World". Milan. |
2018-06-16 |
| Alexandria Real Estate Equities, Inc.. (6/14/18). "Press Release: Alexandria LaunchLabs, the Premier Life Science Startup Platform, Strategically Located at the Alexandria Center for Life Science - NYC, Celebrates First Anniversary". New York, NY. |
2018-06-14 |
| University of Zurich [Stefan Stöcklin]. (6/13/18). "Press Release: Life Sciences Spin-off. Anaveon Backs Immunotherapy". |
2018-06-13 |
| MorphoSys AG. (6/12/18). "Press Release: New Phase 3 Clinical Trials by MorphoSys’s Partner with Gantenerumab in Early Alzheimer's Disease now Underway". Planegg. |
2018-06-12 |
| Andrew Alliance S.A.. (6/12/18). "Press Release: Andrew Alliance Raises $14m from Top Life Sciences Industry Partners and Global Investors". Geneva. |
2018-06-12 |
| Memo Therapeutics AG. (6/11/18). "Press Release: Memo Therapeutics AG Announced that Dr. Karsten Fischer Was Appointed as Chief Executive Officer of the Company Effective June 01, 2018". Basel. |
2018-06-11 |
| Idorsia Ltd.. (6/11/18). "Press Release: Idorsia Initiates a Phase 3 Registration Program with Nemorexant (ACT-541468) for the Treatment of Insomnia". Allschwil. |
2018-06-11 |
| Nordic Nanovector ASA. (6/1/18). "Press Release: Nordic Nanovector Strengthens Management Team with Appointment of Maureen Deehan, PhD, as Head of Corporate Development and Strategy". Oslo. |
2018-06-01 |
| InterAx Biotech AG. (5/31/18). "Press Release: InterAx Biotech and Vrije Universiteit Amsterdam Enter a Collaboration to Unlock Novel Chemical Space for Chemokine Therapeutics". Villigen & Amsterdam. |
2018-05-31 |
| CRISPR Therapeutics AG. (5/30/18). "Press Release: CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease". Boston, MA, Zug & Cambridge, MA. |
2018-05-30 |
| Biognosys AG. (5/30/18). "Press Release: Introducing PQ500". |
2018-05-30 |
| Roche. (5/29/18). "Press Release: Phase III IMpower130 Study Showed Roche’s Tecentriq (atezolizumab) plus Chemotherapy (carboplatin and Abraxane) Helped People with Metastatic Non-squamous NSCLC Live Significantly Longer Compared to Chemotherapy Alone". |
2018-05-29 |
| Lunaphore Technologies S.A.. (5/24/18). "Press Release: Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets". Lausanne & Seville. |
2018-05-24 |
| Lonza Group Ltd.. (5/22/18). "Press Release: Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells". Basel. |
2018-05-22 |
| Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel. |
2018-05-21 |
| Pierre Fabre S.A.. (5/18/18). "Press Release: Pierre Fabre and Roche Extend Collaboration Agreement on Companion Diagnostic Development". Castres. |
2018-05-18 |
| Roche. (5/17/18). "Press Release: Phase III IMpower150 Study Showed Roche’s Tecentriq and Avastin plus Carboplatin and Paclitaxel Helped People with a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin plus Carboplatin |
2018-05-17 |
| Roche. (5/17/18). "Press Release: Follow-up Phase III Data Showed Roche’s Alecensa Helped People with ALK-positive Metastatic Non-Small Cell Lung Cancer Live a Median of Almost Three Years Without Their Disease Worsening or Death". Basel. |
2018-05-17 |
| Idorsia Ltd.. (5/16/18). "Press Release: Idorsia Initiates MODIFY, a Phase 3 Registration Study to Assess Lucerastat as a Potential New Treatment Option for Patients with Fabry Disease". Allschwil. |
2018-05-16 |
| CRISPR Therapeutics AG. (5/15/18). "Press Release: CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting". Zug & Cambridge, MA. |
2018-05-15 |
| Novartis AG. (5/15/18). "Press Release: Novartis Successfully Completes Acquisition of AveXis, Inc.". Basel. |
2018-05-15 |
| Valerius Biopharma AG. (5/14/18). "Press Release: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars". Somerset, NJ & Basel. |
2018-05-14 |
| Polyneuron Pharmaceuticals AG. (5/14/18). "Press Release: Polyneuron Pharmaceuticals Completes CHF3.1 Million Seed Financing". Basel. |
2018-05-14 |
| Agilent Technologies Inc.. (5/14/18). "Press Release: Agilent Completes Acquisition of Genohm". Santa Clara, CA. |
2018-05-14 |
| Memo Therapeutics AG. (5/9/18). "Press Release: Memo Therapeutics AG Closes Series A2 Financing Round of CHF 5 Million to Advance Its Antibody Discovery Programs into Preclinical and Clinical Development". Basel. |
2018-05-09 |
| Novartis AG. (5/9/18). "Press Release: Essential Consultants – Novartis Statement". |
2018-05-09 |
| Celonic AG. (5/8/18). "Press Release: Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy". Basel. |
2018-05-08 |
| CRISPR Therapeutics AG. (5/8/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results". Zug & Cambridge, MA. |
2018-05-08 |
| Lonza Group Ltd.. (5/4/18). "Press Release: Lonza Reports Positive Start to 2018 with Businesses Along the Healthcare Continuum as Growth Drivers". Basel. |
2018-05-04 |
| Lonza Group Ltd.. (5/4/18). "Press Release: Lonza to Invest in Portsmouth, NH (USA) Site, including Mid-Scale Biologics". Portsmouth, NH & Basel. |
2018-05-04 |
| Agilent Technologies Inc.. (5/2/18). "Press Release: Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm". Santa Clara, CA. |
2018-05-02 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
